O uso profilático de fatores de crescimento, estimuladores de colônias hematopoéticas, em pacientes oncológicos submetidos à quimioterapia
Fay, André Poisl; Barrios, Carlos Henrique E.
Acta méd. (Porto Alegre)
; 28: 429-434, 2007.
Artigo em Português | LILACS | ID: lil-478528
Documentos relacionados
NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022.
NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.
Are guidelines on use of colony-stimulating factors in solid cancers flawed?
[Hematopoietic growth factors, a dilemma for the clinician].
Medication overuse in oncology: current trends and future implications for patients and society.
Hematopoietic growth factors: personalization of risks and benefits.
[Use of hematopoietic growth factors in oncology].
Use of haemopoietic growth factors: commentary on the ASCO/ECOG guidelines. American Society of Clinical Oncology/Eastern Co-operative Oncology Group.
[Importance of recombinant proteins in the adjuvant treatment of cancer].
The hematopoietic growth factors in acute leukemia: a European perspective.